Literature DB >> 32243612

WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): from bedside to phone-side.

D Jakhar1, S Kaul2, I Kaur1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32243612      PMCID: PMC9213937          DOI: 10.1111/ced.14227

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   4.481


× No keyword cloud information.
The current coronavirus disease (COVID‐19) has forced the shutdown of many nonessential services in most high‐risk countries. Most Dermatology consultations (except emergencies) have been deferred as a precautionary measure to prevent the spread of COVID‐19, but patients continue to arrive at clinics and hospitals. While clinicians want to help, the current COVID‐19 pandemic demands that they be extra vigilant and exercise caution in choosing which patients to see. A solution may be offered in the form of teledermatology using everyday tools/devices. Telemedicine is defined as the use of electronic information and communication technologies to provide healthcare support when distance separates patients from healthcare professionals with expertise in the field., Vital information can be shared between the two groups in the form of text, audio, still images and video., It is true that we were not prepared for this pandemic, and many healthcare setups are still not well equipped for telemedicine. Few clinicians have a thorough knowledge of telemedicine/teledermatology and fewer patients are aware that this exists in medicine. The current situation of teledermatology is even worse in developing countries. However, the use of mobile technology is rapidly expanding within the field of telemedicine. Audiovisual communication, aided by smartphone applications, is a novel concept in teledermatology. WhatsApp is currently one of the most popular applications worldwide, and allows its users to communicate via text/voice messages, photos and videos., The need for only a mobile Internet connection, with no extra cost for sharing unlimited information, makes it a useful platform for social interaction. Although sparse, there is literature exploring WhatsApp as a potential telecommunication tool in medicine. Dermatology is one of the few fields of medicine where visual inspection is paramount for making a diagnosis. The ease of use, portability, speed, cost‐effectiveness and simplicity makes WhatsApp a good adjunctive teledemedicine tool. Familiarity with the application is the biggest advantage and fosters patient confidence. The options to send pictures and to interact via text/voice messages or video calls can offer sufficient material for management of a dermatosis, provided a diagnosis can be made. This method of communication is especially beneficial for those with an established diagnosis who need follow‐up. The utility of this application in sharing investigation reports and previous treatment charts is another added advantage. Generally, teledermatology can be delivered as real‐time video consultation (RT‐TD) or as an asynchronous store‐and‐forward (SAF) service. WhatsApp can deliver both RT‐TD (through video and/or audio chat) and SAF (patient can send the picture and/or text, and the dermatologist can reply at a convenient time). Limitations such as poor‐quality pictures, medicolegal responsibility, privacy and ethical issues (as with any other mode of teledermatology) remain., Consultation fees and mode of payment are other unclear areas. More importantly, further research is warranted in this field to define the role of such apps in dermatology. In these times of COVID‐19 and the need for social distancing, not many dermatologists are familiar with teledermatology, and WhatsApp can serve as an interface between patients and dermatologists. What other option do we have? We should have been better prepared. Perhaps this presents an opportunity to invest in learning and implementing teledermatology in clinical practice so we can face any future challenges.
  7 in total

Review 1.  Introduction to the practice of telemedicine.

Authors:  John Craig; Victor Patterson
Journal:  J Telemed Telecare       Date:  2005       Impact factor: 6.184

Review 2.  What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings.

Authors:  Sanjay Sood; Victor Mbarika; Shakhina Jugoo; Reena Dookhy; Charles R Doarn; Nupur Prakash; Ronald C Merrell
Journal:  Telemed J E Health       Date:  2007-10       Impact factor: 3.536

3.  Smartphone applications in palliative homecare.

Authors:  Sunil R Dhiliwal; Naveen Salins
Journal:  Indian J Palliat Care       Date:  2015 Jan-Apr

4.  Efficacy of communication amongst staff members at plastic and reconstructive surgery section using smartphone and mobile WhatsApp.

Authors:  Shabeer Ahmad Wani; Sari M Rabah; Sara Alfadil; Nancy Dewanjee; Yahya Najmi
Journal:  Indian J Plast Surg       Date:  2013-09

5.  WhatsApp Messenger as an Adjunctive Tool for Telemedicine: An Overview.

Authors:  Vincenzo Giordano; Hilton Koch; Alexandre Godoy-Santos; William Dias Belangero; Robinson Esteves Santos Pires; Pedro Labronici
Journal:  Interact J Med Res       Date:  2017-07-21

6.  Recent trends in teledermatology and teledermoscopy.

Authors:  Katie J Lee; Anna Finnane; H Peter Soyer
Journal:  Dermatol Pract Concept       Date:  2018-07-31

7.  Smartphone usage in the 21st century: who is active on WhatsApp?

Authors:  Christian Montag; Konrad Błaszkiewicz; Rayna Sariyska; Bernd Lachmann; Ionut Andone; Boris Trendafilov; Mark Eibes; Alexander Markowetz
Journal:  BMC Res Notes       Date:  2015-08-04
  7 in total
  25 in total

1.  Direct-to-Patient Teledermatology During COVID-19 Lockdown in a Health District in Madrid, Spain: The EVIDE-19 Pilot Study.

Authors:  E Sendagorta; G Servera; A Nuño; R Gil; L Pérez-España; P Herranz
Journal:  Actas Dermosifiliogr       Date:  2021-02-03

2.  Facing Confinement, the Comfort of WhatsApp Groups in Mental Health Communities.

Authors:  Emmanuel Stip; Fadwa Al Mugaddam; Leena Amiri
Journal:  Can J Psychiatry       Date:  2020-08-12       Impact factor: 4.356

3.  Personal Experiences With Coronavirus Disease 2019 and Diabetes: The Time for Telemedicine is Now.

Authors:  Julia K Mader
Journal:  J Diabetes Sci Technol       Date:  2020-05-22

4.  Teledermatology Services during COVID-19 Pandemic: Experience of a Tertiary Care center in Western India.

Authors:  Anupama Bains; Afroz Alam; Saurabh Singh; Anil Budania; Suman Patra; Abhishek Bhardwaj
Journal:  Indian Dermatol Online J       Date:  2022-06-24

5.  Secure communication conduits during COVID-19 lockdown.

Authors:  S M Black; F R Ali
Journal:  Clin Exp Dermatol       Date:  2020-05-24       Impact factor: 3.470

6.  Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak.

Authors:  Zixin Pi; Pan Chen; Yi Zhan; Rong Xiao
Journal:  Clin Dermatol       Date:  2020-08-05       Impact factor: 3.541

7.  Teledermatology during COVID-19 pandemic: Ethical and legal considerations about the principles of treatment prescription and privacy.

Authors:  Ömer Faruk Elmas; Abdullah Demirbaş; Mustafa Atasoy; Ümit Türsen; Torello Lotti
Journal:  Dermatol Ther       Date:  2020-07-02       Impact factor: 3.858

Review 8.  COVID-19 and dermatology: a comprehensive guide for dermatologists.

Authors:  D H Fahmy; H S El-Amawy; M A El-Samongy; A A Fouda; S H Soliman; A El-Kady; F Farnetani; A Conti; A Zoeir; A Eissa; R Eissa; S Puliatti; M C Sighinolfi; B Rocco; G Pellacani
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-10       Impact factor: 9.228

9.  Management of telogen effluvium during the COVID-19 emergency: Psychological implications.

Authors:  Nicolò Rivetti; Stefania Barruscotti
Journal:  Dermatol Ther       Date:  2020-06-05       Impact factor: 3.858

10.  Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic.

Authors:  C Marasca; A Ruggiero; G Fontanella; M Ferrillo; G Fabbrocini; A Villani
Journal:  Clin Exp Dermatol       Date:  2020-05-28       Impact factor: 3.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.